Skip to main contentSkip to navigation
Sirius Investors
China Jo-Jo Drugstores, Inc.

China Jo-Jo Drugstores, Inc.

CJJD
NASDAQHealthcare

China Jo-Jo Drugstores, Inc. (CJJD) Financial Metrics

This dashboard provides comprehensive financial metrics and analysis to help evaluate China Jo-Jo Drugstores, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.

Financial Metrics Score

Valuation Metrics

Sector benchmarks: Industrials

2025
P/E Ratio
0.00
Strong
WeakModerateStrong
P/B Ratio
0.00
Strong
WeakModerateStrong
Earnings Yield
263.12%
Strong
WeakModerateStrong

Profitability Health

2025
Return on Equity
34.40%
Strong
WeakModerateStrong
Operating Margin
-0.86%
Weak
WeakModerateStrong
Net Profit Margin
8.50%
Moderate
WeakModerateStrong

Growth Indicators

2025
Revenue Growth
3.85%
Weak
WeakModerateStrong
Net Income Growth
79.97%
Strong
WeakModerateStrong
EPS Growth
92.93%
Strong
WeakModerateStrong

Efficiency & Liquidity

2025
Current Ratio
1.74
Moderate
WeakModerateStrong
Quick Ratio
1.45
Moderate
WeakModerateStrong
Asset Turnover
1.86x
Strong
WeakModerateStrong
Inventory Turnover
11.90x
Strong
WeakModerateStrong

Cash Flow & Resilience

Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes

2025
Free Cash Flow Yield
16.32%
Strong
WeakModerateStrong
EV / Free Cash Flow
-3.72x
Strong
WeakModerateStrong
Net Debt / EBITDA
-0.48x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.918
Moderate
WeakModerateStrong
Return on Invested Capital
-2.56%
Weak
WeakModerateStrong
Cash Conversion Cycle
60.83 days
Weak
WeakModerateStrong

Fortress screener guardrails

2/4 passing
  • FCF Yield > 3%
  • Net Debt / EBITDA < 1.5x
  • ROIC > 20%
  • Cash Conversion Cycle < 0 days

Financial Statements

Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for CJJD.

View Financial Statements